 |
|
|
Five new trending stocks to watch: |
|
|
OSBC, RBY, GST, DNKN, QCOR. |
|
|
Released on Friday, June 29, 2011, 8:00 AM ET
Pittsburgh, PA (SpeculatingStocks) – It is important to watch stocks that are trending. Those trend stocks that are catching the eyes of investors and seeing increased volume and price action. Investors and traders who visit SpeculatingStocks.com can find trending stocks on our homepage.
OSBC (Old Second Bancorp, Inc.) – OSBC is trading at a market cap of less than $20 million. The company just reported Q2 net income of $1.0 million. The CEO of the company commented, “While uncertainty remains in the broader economy, we have seen signs of stabilization in commercial real estate values in our market area, which we believe will be a key to our continuing improvement.” OSBC closed up $0.27 to $1.30 in its last session and has a 52-week high of $2.47.
RBY (Rubicon Minerals Corporation) – RBY is involved in the exploration, acquisition and development of mineral properties in Canada and the US. Rubicon just announced a significant strategic investment of C$70 million by way of a non-brokered private placement of common shares. The securities issued are subject to a four-month hold period, expiring November 29, 2011. RBY gapped higher on this news.
GST (Gastar Exploration, Ltd.) - GST is a Marcellus Shale play with acreage in the Appalachian area of West Virginia, and central and southwestern Pennsylvania. GST is trading at $4.86 and nearing its 52-week high at $5.44.
DNKN (Dunkin’ Brands Group) – DNKN just went public a couple of days ago. The IPO market is very hot, but mostly for social media stocks. DNKN still received a good bit of attention. DNKN operates under the Dunkin’ Donuts and Baskin-Robbins brands. DNKN plans to release its Q2 2011 earnings before the bell on Wednesday, August 3.
QCOR (Questcor Pharmaceuticals, Inc.) – QCOR has been one of the hottest pharmaceutical stocks out there. QCOR has trended from under $5.00 in February of 2010 to over $30.00 now. QCOR recently had a record second quarter driven by a 45% rise in shipments of their multiple sclerosis treatment Acthar.
Stay up to date on new trending stocks through the “Trending Stocks” section on the SpeculatingStocks homepage.
Comments:
